febuxostat has been researched along with calcium oxalate in 4 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (calcium oxalate) | Trials (calcium oxalate) | Recent Studies (post-2010) (calcium oxalate) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 4,535 | 119 | 1,430 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldfarb, DS | 1 |
| Chefo, S; Goldfarb, DS; Gunawardhana, L; MacDonald, PA; McLean, L | 1 |
| Arowojolu, O; Goldfarb, DS | 1 |
| Inoue, S; Ishigaki, Y; Miyazawa, K; Nakai, D; Nakamura, Y; Nakazawa, Y; Tatsuno, T | 1 |
2 review(s) available for febuxostat and calcium oxalate
| Article | Year |
|---|---|
Potential pharmacologic treatments for cystinuria and for calcium stones associated with hyperuricosuria.
Topics: Animals; Calcium Oxalate; Crystallization; Cystinuria; Drugs, Investigational; Febuxostat; Humans; Kidney; Kidney Calculi; Secondary Prevention; Thiazoles; Treatment Outcome; Uric Acid; Uricosuric Agents | 2011 |
Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
Topics: Allopurinol; Biomarkers; Calcium Oxalate; Febuxostat; Humans; Indapamide; Kidney; Nephrolithiasis; Risk Factors; Treatment Outcome; Uric Acid; Uricosuric Agents | 2014 |
1 trial(s) available for febuxostat and calcium oxalate
| Article | Year |
|---|---|
Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.
Topics: Adult; Allopurinol; Biomarkers; Calcium Oxalate; Double-Blind Method; Enzyme Inhibitors; Febuxostat; Female; Humans; Male; Middle Aged; Multidetector Computed Tomography; Thiazoles; Time Factors; Treatment Outcome; United States; Uric Acid; Urinary Calculi; Xanthine Oxidase | 2013 |
1 other study(ies) available for febuxostat and calcium oxalate
| Article | Year |
|---|---|
Effects of the xanthine oxidase inhibitor, febuxostat, on the expression of monocyte chemoattractant protein-1 and synchronous genes in MDCK cells treated with calcium oxalate monohydrate crystals.
Topics: Animals; Calcium Oxalate; Chemokine CCL2; Dogs; Febuxostat; Kidney; Madin Darby Canine Kidney Cells; Xanthine Oxidase | 2021 |